Steve G.
Board Member at NEOGAP Therapeutics AB- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
0
/5.0 / Based on 0 ratingsFilter reviews by:
Experience
-
NEOGAP Therapeutics AB
-
Sweden
-
Pharmaceutical Manufacturing
-
1 - 100 Employee
-
Board Member
-
Jun 2022 - Present
-
-
-
Single Technologies
-
Sweden
-
Biotechnology Research
-
1 - 100 Employee
-
Board Member & Commercial
-
Jun 2020 - Present
-
-
-
-
Board Member
-
Jan 2018 - Present
-
-
-
QuantumCyte, Inc.
-
United States
-
Biotechnology Research
-
Advisor
-
Jan 2018 - Present
-
-
-
Pixelgen Technologies
-
Sweden
-
Biotechnology Research
-
1 - 100 Employee
-
Global Sales
-
Sep 2022 - Sep 2023
-
-
-
Amplexa Genetics A/S
-
Denmark
-
Hospitals and Health Care
-
1 - 100 Employee
-
Board Member
-
Mar 2019 - Mar 2023
-
-
-
Celsee, Inc.
-
United States
-
Biotechnology Research
-
1 - 100 Employee
-
Vice President Sales and General Manager, EMEA
-
Nov 2018 - Apr 2020
-
-
-
10X Genomics
-
United States
-
Biotechnology Research
-
700 & Above Employee
-
Sales Executive at 10X Genomics, Inc
-
Apr 2016 - Jan 2018
Nordic and Benelux Regional Sales and Market Development for single cell analysis and linked read applications. Nordic and Benelux Regional Sales and Market Development for single cell analysis and linked read applications.
-
-
-
Thermofisher Scientific
-
United States
-
Packaging and Containers
-
1 - 100 Employee
-
Clinical Account Manager
-
Dec 2014 - Apr 2016
Clinical Account Manager for Next Generation Sequencing platforms within Oncology utilizing Ampliseq and Oncomine product portfolio. Clinical Account Manager for Next Generation Sequencing platforms within Oncology utilizing Ampliseq and Oncomine product portfolio.
-
-
-
-
Head of NGS
-
May 2012 - Dec 2014
Design and implement a clinical NGS platform for handling widely varying sample types with response time under 24 hours, outbreak tracing, typing. Lead development of bioinformatics solutions for automating design and handling of samples. Design and implement a clinical NGS platform for handling widely varying sample types with response time under 24 hours, outbreak tracing, typing. Lead development of bioinformatics solutions for automating design and handling of samples.
-
-
-
Life Technologies
-
United States
-
Biotechnology Research
-
700 & Above Employee
-
Senior Instrument Sales Rep Nordics & Baltics - NGS (SOLiD, Ion Torrent)
-
Jan 2011 - May 2012
-
-
Senior Field Applications Specialist - SOLiD
-
Mar 2010 - Dec 2010
-
-
-
-
Molecular Biologist
-
Aug 2008 - Dec 2009
-
-
-
-
Field Applications Specialist
-
Oct 2005 - Jul 2008
-
-
-
-
Scientist
-
Oct 2003 - Jun 2005
-
-
-
-
Research Associate
-
Sep 2001 - Jan 2002
-
-
-
Siemens Enterprise Networks
-
Telecommunications
-
Call Center Design Specialist
-
Feb 1999 - Jun 2001
-
-